Cardiomyopathy

October 18, 2018

A cup of probiotic a day keeps cardiac diseases at bay: Probiotic Lactobacillus pentosus var. plantarum C29 inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 18/October/2018, 11.19 pm

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac aging and function.” This study was published, in the 7 March  2013 issue of the […]
September 25, 2018

A probiotic way to keep the cardiac diseases at bay: Probiotic Lactobacillus brevis-based Regenerative therapy for regaining the lost cardiomyocytes in Myocardial patients:  Probiotic Lactobacillus brevis increases the expression of ERBB2/Her2 and promotes dedifferentiation  of cardiomyocytes via down-regulation of its target gene, 25/September/2018, 9.29 pm

Introduction: What they say A recent study from the Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel shows that “ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.” This study was […]
August 27, 2018

A sere(ne)laxin-way to stay free of cardiac diseases: Serelaxin-based therapy for attenuating pathogenesis-associated with Myocardial infarction: Serelaxin, a recombinant Relaxin-2,  decreases IRF3 (Interferon regulatory transcription factor-3), GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up-regulation of its target gene, 27/August/2018, 11.25 pm

Introduction: What they say: A recent study from Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA; and Cardiovascular Research Center, Massachusetts General Hospital and […]
August 26, 2018

Repurposing the reproductive hormone relaxin into a cardioprotective drug : Cardiac rejuvenation therapy: Relaxin, a protein hormone that facilitates labor and relaxes the uterine musculature, suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy via upregulation of its target gene, 26/August/2018, 11.30 pm

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Repurposing the reproductive hormone relaxin into a cardioprotective drug : Cardiac rejuvenation therapy: Relaxin, a […]